HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

AG 556

structure given in first source
Also Known As:
2-cyano-3-(3,4-dihydroxyphenyl)-N-(4-phenylbutyl)-2-propenamide; AG-556; AG556; N-(4-phenylbutyl)-3,4-dihydroxybenzylidene cyanoacetamide; alpha-cyano-(3,4-dihydroxy)-N-(4-phenylbutyl)cinnamide; tyrphostin AG556; tyrphostin B56
Networked: 20 relevant articles (6 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Keren, Pnina: 3 articles (06/2005 - 06/2003)
2. Keren, Gad: 3 articles (06/2005 - 06/2003)
3. Roth, Arie: 3 articles (06/2005 - 06/2003)
4. George, Jacob: 3 articles (06/2005 - 06/2003)
5. Barshack, Iris: 3 articles (06/2005 - 06/2003)
6. Levitzki, Alexander: 3 articles (06/2005 - 06/2003)
7. Alver, Ahmet: 2 articles (04/2014 - 01/2004)
8. Genovese, Tiziana: 2 articles (06/2007 - 11/2005)
9. Di Paola, Rosanna: 2 articles (06/2007 - 11/2005)
10. Mazzon, Emanuela: 2 articles (06/2007 - 11/2005)

Related Diseases

1. Septic Shock (Toxic Shock Syndrome)
2. Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
3. Sepsis (Septicemia)
4. Multiple Sclerosis
5. Infection

Related Drugs and Biologics

1. AG 127 (AG 126)
2. Protein-Tyrosine Kinases (Tyrosine Kinase)
3. Tyrphostins
4. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
5. Messenger RNA (mRNA)
6. Oxygen
7. Norepinephrine (Noradrenaline)
8. Dimethyl Sulfoxide (DMSO)
9. Myosins (Myosin)
10. Ringer's lactate

Related Therapies and Procedures

1. Resuscitation
2. Laminectomy